What inspired you to become a reproductive biologist?
My interest in reproductive biology stemmed from a research experience I had as an undergraduate at Haverford College. I received an HHMI fellowship to perform basic research over the summer and for my senior thesis project. I worked with Dr. Karl Johnson who used the model organism Chlamydomonas reinhardtii to study the flagella -specifically to understand the mechanisms of microtubule assembly and intraflagellar transport. My project was to investigate whether tubulin isoforms dictated protofilament diameter. During this time, I caught the research bug and really enjoyed the scientific pipeline of asking questions, developing hypotheses, performing research, analyzing data, and interpreting results that opened the door to more questions. However, I wanted to study something more translational; I wanted to be as close to medicine as possible without actually going to medical school. To this end, I began thinking about what other cells have flagella, and of course, I came up with sperm, which led me to reproductive biology. I became completely entranced by the concept that two single cells, a sperm and an egg, can unite at the time of fertilization and give rise to an entirely new generation that itself is composed of billions of cells. I was determined to explore the potential energy of these germ cells. I started my graduate career studying sperm biology and was inspired by researchers such as Dr. Greg Kopf, Dr. George Gerton, Dr. Stuart Moss, and Dr. Pablo Visconti. However, I ultimately became an egg biologist (this transition is another story in itself), and I have been fortunate to have been mentored by an amazing group of individuals in this area, including Dr. Carmen Williams, Dr. Richard Schultz, and Dr. Teresa Woodruff. I am proud to say that I have been in the field of reproductive biology since the beginning of my graduate training, which is now verging on 20 years! Our field is exceptionally welcoming and supportive, and I cannot imagine being any other place.
Who are the past and current scientists whom you admire and inspired your research?
Dr. John Eppig has greatly inspired me as a scientist. Dr. Eppig performed pioneering research that established the critical importance of bi-directional communication and metabolic cooperativity between the oocyte and its companion granulosa cells, and it is no surprise that he was elected into the National Academy of Sciences for his contributions. The mammalian oocyte cannot use glucose as an energy substrate, cannot make certain amino acids, and lacks the enzymatic system for synthesizing cholesterol and is unable to take it up from the environment. In a series of elegant Figure 1 . The ovarian microenvironment in which follicles grow and develop changes dramatically with advanced reproductive age. These images show histological sections of ovaries from reproductively (A) young (6-12 weeks old) and (B) old (14-17 months old) CB6F1 mice stained with an antibody against collagen IV. As expected, the number of follicles in the ovary decline with age, but there are still growing follicles present within ovaries from young and old mice (arrows). Although these growing follicles appear morphologically indistinguishable from each other, the microenvironments in which they are developing are clearly different as evidenced by the collagen IV distribution. We now know that the aging ovarian microenvironment is characterized by increased fibrosis and inflammation and are currently investigating how this impacts gamete quality. Images taken by John Kelsh (Duncan Lab, undergraduate trainee, 2014-2016). studies, Dr. Eppig's research group defined the precise paracrine signaling mechanisms the mammalian oocyte uses to stimulate these metabolic pathways in the surrounding somatic cells. This metabolic cooperativity satisfies the metabolic deficiencies of the oocyte and outsources catabolic metabolism to the granulosa cells to protect the oocyte from potentially harmful oxidative stress. As an "eggcentric" individual and one who fully believes that "Ex Ovo Omnia" ("From the Egg, All"), my all-time favorite publication is one in which Dr. Eppig demonstrated that the oocyte is the front seat driver in this metabolic cooperativity [3] . Using ovary re-aggregation experiments, Dr. Eppig convincingly showed that the oocyte orchestrates the rate of follicle development. Specifically, aggregating oocytes from secondary follicles with somatic cells from primordial follicles accelerates follicle development by two-fold. When you read any of Dr. Eppig's publications, one will immediately appreciate that the scientific questions are crystal clear, the methods are straightforward and direct, the results are easy to follow, and the conclusions are spot on and profound. I encourage all trainees in our field to read at least one of Dr. Eppig's publications as they are a terrific template for scientific thinking.
This past year, you won the New Investigator Award from the SSR. This award recognizes the research accomplishments made so far in your career. Of all of your outstanding accomplishments, which do you think is the most important to date? Why?
I consider that, to date, my laboratory's most outstanding accomplishment is defining how the ovarian stroma or microenvironment changes with advanced reproductive age [4] . In particular, we documented that reproductive aging is associated with increased stromal fibrosis and inflammation. This topic, which is now the focus of my laboratory, actually started out as a side project because of difficulties we encountered-a true example of turning lemons into lemonade. We were trying to isolate primary and secondary stage follicles from ovaries of reproductively young and old mice to analyze changes in the growing oocyte that occur during aging ( Figure 1 ). However, we had extreme difficulty isolating follicles from ovaries from reproductively old mice because the tissue was physically tougher. This phenotype was robust and tangible and inspired us to look further into what was happening at the tissue level. My lab ultimately started a fruitful and ongoing collaboration with Dr. Michele Pritchard, a liver injury and regeneration researcher. Together, we have brought tools for evaluating fibrosis to the mammalian ovary, and we are currently examining mechanisms underlying fibrosis-focusing on changes to the ovarian hyaluronan matrix. I consider our work on ovarian fibrosis, a major research accomplishment because it has reinvigorated the field's interest in the ovarian stroma. The stroma is not simply an "amorphous ground substance" as it was once called, but rather a dynamic component of the ovary that changes through development, aging, and disease and likely has profound influences on the gametes that develop within it. On a personal note, this discovery taught me the importance of being malleable in my thinking and going where the research leads me. The detour can often be the most exciting part of the journey!
What do you consider the greatest breakthroughs in the field of reproductive biology and why?
I think the greatest breakthrough in our field has been the advent and success of Assisted Reproductive Technologies (ART) (e.g. in vitro fertilization, intracytoplasmic sperm injection, and preimplantation genetic testing), which account for the lives of millions of individuals worldwide. Our ability to support fertilization and the very earliest stages of preimplantation embryo development outside of the body has revolutionized the way we reproduce and has tremendous clinical implications for humans as well as agricultural implications in animals. We are continuously pushing the envelope in this arena as efforts are underway to derive gametes from more and more naïve cells, to support a continuum of gamete development entirely in vitro, to modify the germ line to improve outcomes, and beyond. These astounding advances of course are not without their concerns, and have spurred the growth of research at the intersection of ART and epigenetics, ART and the developmental origins of adult disease, and ART and transgenerational impacts. Moreover, they have fueled careful consideration and necessary discussion of ethics and regulations in tandem to research discoveries.
What advice do you have for junior investigators who want to succeed in the field of reproductive biology?
I have two main pieces of advice for junior investigators who want to succeed in reproductive biology. The first is a piece of advice my mentor Richard Schultz gave me, which is to "study robust phenotypes." This is a simple statement, but a profound one. In fact, I remind myself of this statement on almost a daily basis at the experimental level but also when thinking about broader research topics. If a phenotype is not robust (i.e. subtle and not always reproducible), you run a high risk of being misled and going down the wrong path. I have heeded this advice in my own research career because I have made it a point to study one of the most robust phenotypes in biology: female reproductive aging. This biological phenomenon will impact every single female in her lifetime at precisely the same age irrespective of her race, ethnicity, and geography, and reproductive aging has tangible clinical and health consequences. The phenotype is there; our job is to unravel the mechanisms. My second piece of advice is to think beyond our field. When I was a graduate student, I was hyper-focused on my project, and I would consider seminars and activities not directly in my research sphere to be distracting and not relevant. This could not be farther from the truth, and in fact, one of my favorite papers is from Dr. Brian Uzzi's group which examined the origin of high impact papers [5] . It turns out that, perhaps not surprisingly, "the highest-impact science is primarily grounded in exceptionally conventional combinations of prior work yet simultaneously features an intrusion of unusual combinations." My scientific innovation and highest impact work has come, not from earth shattering revelations or visions, but rather from simply embedding myself in different fields, ranging from aging to neuroscience to liver fibrosis and regeneration. This has exposed me to entirely new perspectives, research questions, and tools that I am then able to apply to the reproductive biology field in an entirely new way.
What is your philosophy for mentoring reproductive biology trainees?
One of the biggest privileges of being a scientist in academia is training the next generation of leaders in reproductive biology and ensuring that the knowledge we learned is passed on and built upon moving forward. Although I have only had my own laboratory for 5 years, I have been fortunate to train individuals at various points of their training, ranging from high school students and undergraduates to graduate students, post-doctoral fellows, medical students and residents, and international scholars. Through these experiences, I have learned that, in the correct environment and with proper support, all trainees are capable of success. My philosophy for mentoring is that each trainee should have his/her own research project irrespective of their level, and they should be aware of all factors that enable them to do their science. For example, if their studies are based on a funded project, I provide trainees with the actual proposal and relevant references; if they use animals or human subjects, I provide them with the appropriate regulatory documents to review; if their project is collaborative, I include them in all meetings and on all communications with the research team; if they are submitting a manuscript, I include them in all aspects of the submission and review process. I have found that this type of transparency helps to demystify the scientific process, establishes project ownership, and ultimately contributes to research independence. I also encourage my trainees to begin presenting their work at scientific forums as soon as possible and as often as possible.
Having to distill and discuss research findings on a continuous basis is a terrific way to learn how to communicate, receive essential project feedback, to increase visibility in the field, to strike up new collaborations, and to work iteratively toward publication. For example, we often use posters as story boards or visual outlines for manuscripts.
What do you love most about your career?
I love the freedom and flexibility of being a scientist and researcher in academia. There is complete intellectual liberty as well as the ability to completely shape the trajectory of your own career. Each and every day is completely different in terms of discoveries and challenges. As a scientist, you continuously develop and sharpen multiple skill sets. Beyond a scientist and researcher, you are a writer, orator, teacher, graphic artist, advocate, small business executive, manager, and beyond. It is simply impossible to be bored in this line of work. I also very much enjoy sharing ideas and learning from people in different disciplines. A major perk of this career is that we can select who we work with, and many colleagues and collaborators often turn out to be wonderful lifelong friends. Another benefit of this career, which is not often verbalized, is how much we travel internationally to meet with collaborators, present our work, and participate in scientific meetings. Through my career as a scientist, I have been able to see amazing parts of the world that I never imagined-from almost all of the United States to beyond, including Argentina, Germany, Italy, France, Belgium, the Netherlands, Spain, Japan, and more.
What do you see as the future for research in reproductive biology?
Science is often reductionist; we study cells in isolation of their native tissue, or we break down a process or a pathway to deconvolute individual components. Although these mechanistic approaches are essential to our knowledge of how things work, I think the future for research in our field lies in engineering complexity back into systems and models and understanding how various factors intersect to impact biology. For example, there are several reproductive biologists on a quest to identify what makes a high quality gamete. To be successful on this endeavor, we cannot just consider the gametes themselves, but rather, we must consider their broader environment ( Figure 2 ). We must integrate how physiology, nutrition and health, disorders and disease conditions, exposures, and epigenetics converge and connect to influence the ultimate developmental potential of the gamete. Now more than ever we are poised to do this by harnessing new technologies, emerging almost on a daily basis, to interrogate biology at the single cell level on an unprecedented scale.
